CVSGF (CVS Group) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


CVSGF CVS Group PLC CVSGF
90 GF Score
Price $16.55
GF Value $18.82
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is CVS Group Research & Development?

CVS Group CVSGF 90 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $18.82 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CVS Group's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

CVS Group  (OTCPK:CVSGF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CVS Group Research & Development Related Terms

CVS Group Research & Development Historical Data

* Premium members only.

The historical data trend for CVS Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Group Research & Development Chart

CVS Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CVS Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CVSGF
90GF Score
CVS Group PLC CVSGF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
CVS Group (CVSGF) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CVS Group and its competitors.
Is CVS Group's Research & Development too high?
CVS Group's current Research & Development is $0.0 Mil. Overall, CVS Group has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's Research & Development compare to HCA and THC?
CVS Group's Research & Development of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CVS Group and its competitors. CVS Group's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.82, compared to a current price of $16.55 — trading 12.1% below its estimated fair value. The current Research & Development is $0.0 Mil. CVS Group's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CVS Group (CVSGF), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Group (CVSGF) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Group stock appears to be undervalued. The current stock price of $16.55 is trading 12.1% below its estimated GF Value™ of $18.82. GuruFocus considers CVS Group to be Modestly Undervalued.

Key valuation signals for CVSGF:

  • Research & Development: $0.0 Mil
  • GF Value™: $18.82 vs. price of $16.55 (12.1% below fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Group Business Description

Other Exchanges CVSGl:UKCVSG:UK4C9:Germany
Address Owen Road, CVS House, Diss, Norfolk, GBR, IP22 4ER
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score

Get the complete analysis for CVSGF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.55
Price
$18.82
GF Value